ARSITEKTUR

Home » All posts

Everything Everywhere reveals business plans

Monday, February 14, 2011 by ARSITEKTUR

T-Mobile and Orange joint venture pledges to increase customers’ productivity by 15% in aggressive strategy to gain corporate share

Everything Everywhere has pledged to increase business customers’ productivity by 15% over the next three years, as part of an aggressive strategy to gain corporate share.

The T-Mobile and Orange joint venture has announced a 'renewed commitment to partnerships' with improved customer service that will see its staff incentivised on customer satisfaction.

Martin Stiven, Everything Everywhere vice president of business, said: ‘Our vision of giving customers access to everything everywhere is extremely powerful for our business customers. Being the UK’s biggest operator gives us a unique opportunity to do something special for business.’

The company said it intends to ‘actively drive partnerships with companies from all sectors’ to provide its business customers with ‘pioneering new products and services’.

Stiven, said: ‘Whether for hardware, software or companies from non-technology fields, we want to work with the very best on partnerships that innovate and provide our customers with something new. At Everything Everywhere we are throwing open our doors to partners who can help us achieve this goal.’

Meanwhile, the company will capitalise on technological advances and the R&D capabilities of parents France Telecom and Deutsche Telekom to deliver new ways of working and increase effectiveness and efficiency for business customers.

Areas of focus will include: Machine to machine, where it will drive a shift in business across transport, retail and the supply chain, as well as enabling new business models such as smart metering; new markets for mobile solutions such as healthcare – the application of advanced technology to increase productivity and reduce costs for health workers and organisations; information everywhere – eliminating artificial restrictions on which device and communications technology to use and integrating core system and business applications across channels and devices to genuinely enable business everywhere; and HD Voice, to open up new applications in noisy environments and provide a better environment for business communications such as conference calls.

All Everything Everywhere business service staff will be based in the UK to ensure they have a 'deep understanding of the commercial challenges faced by customers'.

For small businesses with fewer than 50 employees, Everything Everywhere will use the Orange and T-Mobile brands’ reach through shops, online and channel partnerships with 'focused propositions' targeting specific customer needs.

Meanwhile, the company will develop services and propositions for new medium and corporate customers through a single brand that offers ‘all the benefits’ of Everything Everywhere. The Orange brand will target new large business customers.

Stiven said: ‘Our aim is to significantly increase our business customer base by making the most of our resources and the Orange and T-Mobile brands to target the diverse business audience. We will offer services based on the way businesses want to buy from us.’

Posted in: business, Everything, Everywhere, plans, reveals | 0 comments | |

Simple strategy for slot machines

by ARSITEKTUR

Faced with the aggressive strategy of the simple slot machine, most players use the strategy of conservative stop loss. In this way, are capable of mixing aggression with caution, and therefore get the best of both.

Strategy Run Game Slots strategy is called to execute the game, because it is hitting a machine unless you leave what you want, this strategy leaves no room for sentimentality or instinct, use only the minimum bets that lets you quickly find the best machines. Run the game is a good option for everyone.

Naked and Pulls Limit Loss Before entering the specific approach of running the game, it is first important to understand two concepts that are central to the strategy; Pulls Naked and limit the loss.

Tire means a nude performance with a round win. A player must determine a slot number of spins on a machine that will last without a victory before considering the cold and go to the next machine.

A loss limit is the percentage of your money you’re willing to lose on a machine before leaving it. Between the number of Pulls Naked and the loss limit, their interests will be protected and not continually put a lot of money after the machine has a good bond.

Posted in: machines, Simple, strategy | 0 comments | |

STRATEGIES

by ARSITEKTUR

STRATEGIES

Aggressive

The Aggressive Strategy seeks to grow portfolio asset value through directional investments based on the portfolio managerâ€™s views of the economy, the markets and fundamental investment analysis. Investments in this strategy will typically include a wide array of instruments including, without limitation, stocks, options, bonds, credit derivatives, corporate loans, and funds employing those instruments. This strategy will generally have long, short and hedged positions. It is expected that position concentration could be as high as 10% in any individual investment and 20% in any index or fund.

Moderate

The Moderate Strategy seeks to provide a balance between aggressive growth oriented investments and income producing instruments. Investments in this strategy will typically include a wide array of potential instruments, including, without limitation, stocks, options, bonds, credit derivatives, corporate loans, and funds employing those instruments. The strategy will generally have long, short, and hedged positions. Emphasis will be placed on investment diversification, and it is expected that position concentration could be as high as 5% in any individual investment or 10% in any index or fund.

Conservative

The Conservative Strategy seeks to preserve capital and produce income. A majority of the Account Assets will be invested in fixed income instruments, including, but not limited to, Treasury bonds, municipal bonds, money market funds, certificates of deposit, corporate bonds, corporate loans, and funds employing those instruments. Account Assets may also be invested in the equity markets through instruments such as, but not limited to, dividend paying stocks or funds comprising similar instruments. At the portfolio managerâ€™s discretion, moderate hedges may be used in the Account to reduce risk. Emphasis will be placed on investment diversification, and it is expected that position concentration may be as high as 5% in any individual investment or 10% in any index or fund.

PERFORMANCE

Past performance may not be indicative of future results. Therefore, no current or prospective client should assume that future performance of any specific investment, investment strategy (including the investments and/or investment strategies recommended or undertaken by LHCM) or product made reference to directly or indirectly by LHCM in its web site, or indirectly via a link to an unaffiliated third party web site, will be profitable or equal the corresponding indicated performance level(s). Different types of investments involve varying degrees of risk, and there can be no assurance that any specific investment will either be suitable or profitable for a client or prospective client's investment portfolio. Historical performance results for investment indices and/or categories generally do not reflect the deduction of transaction and/or custodial charges, the deduction of an investment management fee, nor the impact of taxes, the incurrence of which would have the effect of decreasing historical performance results.

Lilly's Rough Patch Has Analysts Questioning Strategy

by ARSITEKTUR

Eli Lilly (LLY), which has taken one body blow after another of late, on Tuesday threw in the towel on its much-anticipated Alzheimer's treatment, semagacestat.

The drug failed in its phase-three trials, Lilly said.

Lilly separately has recently suffered two court losses to generic-drug makers.
Eli Lilly CEO John Lechleiter wants the drugmaker to reinvent its

Eli Lilly CEO John Lechleiter wants the drugmaker to reinvent its "innovation engine," but some analysts want to see a more aggressive strategy. AP View Enlarged Image

Observers say it's time for the company to change strategy and look to make some acquisitions.

That runs smack-dab opposite the strategy extolled by Lilly CEO John Lechleiter. His strategy is "reinventing our innovation engine here," as he put it in an earnings conference call with analysts last month.

But the engine is sputtering. Lilly is appealing a judge's ruling Thursday that invalidated its patent for the ADHD drug Strattera. On Monday, Lilly asked a U.S. District Court to block all generic versions of the drug until Lilly exhausts all appeals.

The patent was to run until 2016.

Generic-drug makers Teva Pharmaceutical (TEVA), Mylan (MYL) and others are ready to launch generic Strattera. Generic competition commonly knocks 80% off the cost of a branded drug.

And on July 28, Lilly failed in another court to protect the patent for its chemotherapy drug, Gemzar. That patent was to expire in 2013.

A failed drug in phase-three trials means a write-off of many millions in already-incurred costs. The loss of a product to generic competition can cost billions in future revenue.

Lilly's stock has fallen more than 9% since Aug. 10, after sliding 2.3% Tuesday to 34.75.

Gemzar sales were $750 million in 2009. Lilly's Strattera sales last year were $600 million worldwide, $450 million in the U.S.

If prices fall 80%, then that's more than $1 billion off the company's top line, which was $22 billion last year. Add it up over the years until patent expiration, and that's more than $5 billion in forgone revenue.

"It's hard to see a reason for the stock to go up without a major pipeline success or without the company making some aggressive strategic moves," said Seamus Fernandez, an analyst with Leerink Swann, which has done business with Lilly.

Lilly's last big deal was its $6.5 billion purchase of ImClone in 2008, though it has made some acquisitions since. Last month, it bought privately held Alnara Pharmaceuticals for an undisclosed sum. Alnara is working on biologic drugs for metabolic diseases.

Posted in: Analysts, Lillys, Patch, Questioning, Rough, strategy | 0 comments | |